<code id='7E48606ACE'></code><style id='7E48606ACE'></style>
    • <acronym id='7E48606ACE'></acronym>
      <center id='7E48606ACE'><center id='7E48606ACE'><tfoot id='7E48606ACE'></tfoot></center><abbr id='7E48606ACE'><dir id='7E48606ACE'><tfoot id='7E48606ACE'></tfoot><noframes id='7E48606ACE'>

    • <optgroup id='7E48606ACE'><strike id='7E48606ACE'><sup id='7E48606ACE'></sup></strike><code id='7E48606ACE'></code></optgroup>
        1. <b id='7E48606ACE'><label id='7E48606ACE'><select id='7E48606ACE'><dt id='7E48606ACE'><span id='7E48606ACE'></span></dt></select></label></b><u id='7E48606ACE'></u>
          <i id='7E48606ACE'><strike id='7E48606ACE'><tt id='7E48606ACE'><pre id='7E48606ACE'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:44
          A yellow number 3 with an eye is surrounded by smaller, black number 3s on a pink background — 3 to watch coverage from STAT
          Christine Kao/STAT

          Health tech hopefuls might once have been used to a wealth of job options, especially in the pandemic’s early stages when investors pumped record-breaking dollar amounts into an unprecedented number of ventures.

          That glut of opportunities meant workers could bargain harder for better job offers, demanding perks and flexibilities like permanent remote work or expensive fertility benefits. But belt-tightening and market consolidation across health tech companies have tipped the scales back in favor of employers, who are continuing to hire — for a seemingly dwindling number of positions.

          advertisement

          It might feel like a downturn, although it’s possible that the industry is simply easing back into its pre-pandemic normal, before the massive infusion of venture dollars and the hype surrounding virtual care, said Brookings Institution research fellow Niam Yaraghi, who studies health care employment.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          ASCO Daily Recap: CAR
          ASCO Daily Recap: CAR

          AdobeYou’rereadingthewebeditionofASCOin30Seconds,STAT’sguidetotheAmericanSocietyofClinicalOncologyan

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          ASCO Takeaways: Winners, snoozers, and the art of cancer care

          ThousandsofoncologistsbadeChicagoagoodnight.ADAMFEUERSTEIN/STATYou’rereadingthewebeditionofASCOin30S